Literature DB >> 15606385

Review article: The eosinophil as a therapeutic target in gastrointestinal disease.

S P Hogan1, M E Rothenberg.   

Abstract

Elevated levels of eosinophils in the gastrointestinal tract is a common feature of numerous gastrointestinal disorders including food allergy, parasitic infections, gastro-oesophageal reflux, eosinophilic oesophagitis, eosinophilic gastroenteritis, allergic colitis and inflammatory bowel diseases. Recently, clinical and experimental studies have provided evidence that eosinophils have a critical role in the pathophysiology of eosinophil-associated gastrointestinal disease. Collectively, these studies have provided relevant insight into identifying key targets for therapeutic intervention. The present review describes recent experimental investigations on the role of eosinophils in the clinical manifestations of eosinophil-associated gastrointestinal disease and discusses future therapeutic approaches for the treatment of disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15606385     DOI: 10.1111/j.1365-2036.2004.02259.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

Review 1.  Eosinophilic esophagitis: a newly established cause of dysphagia.

Authors:  Brian-M Yan; Eldon-A Shaffer
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 2.  Eosinophils in the gastrointestinal tract.

Authors:  Esi S N Lamousé-Smith; Glenn T Furuta
Journal:  Curr Gastroenterol Rep       Date:  2006-10

3.  Preliminary evidence in treatment of eosinophilic gastroenteritis in children: A case series.

Authors:  Ying Chen; Mei Sun
Journal:  World J Clin Cases       Date:  2022-07-06       Impact factor: 1.534

Review 4.  Eosinophilic gastroenteritis: a review.

Authors:  Hwa Eun Oh; Runjan Chetty
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

5.  Attenuation of inflammation and cytokine production in rat colitis by a novel selective inhibitor of leukotriene A4 hydrolase.

Authors:  B J R Whittle; C Varga; A Berko; K Horvath; A Posa; J P Riley; K A Lundeen; A M Fourie; P J Dunford
Journal:  Br J Pharmacol       Date:  2007-12-24       Impact factor: 8.739

6.  Sloughing esophagitis: a not so common entity.

Authors:  Hossein Akhondi
Journal:  Int J Biomed Sci       Date:  2014-12

7.  Fecal Calprotectin as a Useful Non-Invasive Screening Marker for Eosinophilic Gastrointestinal Disorder in Korean Children.

Authors:  In Hyuk Yoo; Jin Min Cho; Jung Yeon Joo; Hye Ran Yang
Journal:  J Korean Med Sci       Date:  2020-05-04       Impact factor: 2.153

8.  Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.

Authors:  Shashi P Singh; Hitendra S Chand; Santanu Banerjee; Hemant Agarwal; Veena Raizada; Sabita Roy; Mohan Sopori
Journal:  Dig Dis Sci       Date:  2019-10-23       Impact factor: 3.199

Review 9.  Eosinophil Function in Eosinophil-associated Gastrointestinal Disorders.

Authors:  Simon P Hogan; Marc E Rothenberg
Journal:  Curr Allergy Asthma Rep       Date:  2006-02       Impact factor: 4.919

Review 10.  Diagnostic approaches and treatment of eosinophilic esophagitis. A review article.

Authors:  Hossein Akhondi
Journal:  Ann Med Surg (Lond)       Date:  2017-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.